An international collaborative program to discover new drugs from tropical biodiversity of Vietnam and Laos

Natural Product Sciences

Volumn 8, Issue 1, 2002, Pages 1-15

  Soejarto, Djaja D ^a   Pezzuto, John M ^a   Fong, Harry H S ^a   Tan, Ghee Teng ^a   Zhang, Hong Jie ^a   Tamez, Pamela ^a   Aydogmus, Zeynep ^a   Chien, Nguyen Quyet ^a   Franzblau, Scott G ^a   Gyllenhaal, Charlotte ^a   Regalado, Jacinto C ^a   Hung, Nguyen Van ^a   Hoang, Vu Dinh ^a   Hiep, Nguyen Tien ^a   Xuan, Le Thi ^a   Hai, Nong Van ^a   Cuong, Nguyen Manh ^a   Quang Bich, Truong ^a   Loc, Phan Ke ^a   Vu, Bui Minh ^a   Southavong, Boun Hoong ^a   Sydara, Kongmany ^a   Bouamanivong, Somsanith ^a   O'Neill, Melanie J ^a   Lewis, Jane ^a   Dietzman, Gregg ^a   more..

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

AIDS; Biodiversity; Cancer; CNS diseases; Drug discovery; ICBG; Laos; Malaria; Medicinal Plants; Plants; Tuberculosis; Vietnam

Indexed keywords

ARDISIA MACULOSA; CLERODENDRUM SERRATUM; DECURSIVINE; DEMETHOXYEPIEXCELSIN; EPIEXCELSIN; EPIGRANDISIN; GLABERIDE; GRANDISIN; HYDROXYDIHYDROBOVOLIDE; LITSEA VERTICILLATA; LITSEAVERTICILLOL A; LOLIOLIDE; MEDIORESINOL; N BUTYLBENZAMIDE; NEW DRUG; PINORESINOL; PLANT EXTRACT; POLYSYPHORIN; RHAPHIDECURSINOL A; RHAPHIDOPHORA DECURSIVA; RHAPIDECURSINOL B; STRYCHNOS VANPRUCKII; SYRINGARESINOL; UNCLASSIFIED DRUG; VATICA CINEREA; VERTICILLATOL;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ALZHEIMER DISEASE; ANTINEOPLASTIC ACTIVITY; ANTIVIRAL ACTIVITY; BIOASSAY; BIODIVERSITY; CANCER; CELL DIFFERENTIATION; CONTROLLED STUDY; CYTOTOXICITY; DRUG ACTIVITY; DRUG ISOLATION; DRUG RESEARCH; DRUG SCREENING; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IC 50; INFORMED CONSENT; INTERNATIONAL COOPERATION; LAOS; MEDICINAL PLANT; MYCOBACTERIUM TUBERCULOSIS; PAIN; PATENT; REVIEW; RHEUMATOID ARTHRITIS; STRUCTURE ANALYSIS; TROPICS; TUBERCULOSIS; VIET NAM;

EID: 0036117730     PISSN: 12263907     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (32)

1. Selective screening of natural products: A resource for the discovery of novel antimalarial compounds
2. Microplate Alamar blue assay versus BACTEC 460 system for high- throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium
3. Quantitative assessment of antimalarial activity in vitro by a semi-automated microdilution technique
4. NAPRALERT as a resource for research on medicinal plants
5. Ethnobotanical aspects of an International Cooperative Biodiversity Group project in Asia
6. Natural anti-HIV agents. Part I. (+)-Demethoxyepiexcelsin and verticillatol from Litsea verticillata
7. In vivo cultivation of tumor cells in hollow fibers
8. The Suriname International Cooperative Biodiversity Group Program: Lessons from the first five years
9. Cytotoxic and antimalarial alkaloids from the bulbs of Crinum amabile
10. NAPRALERT: Computer handling of natural products research data
11. Drug discovery, economic development and conservation: The International Cooperative Biodiversity Groups
12. Combining high-risk science with ambitious social and economic goals
13. Drug development and conservation of biodiversity in West and Central Africa: A model for collaboration with indigenous people
14. New colorimetric cytotoxicity assay for anticancer-drug screening
15. Logistics and politics in plant drug discovery: The other end of the spectrum
16. Biodiversity prospecting: Perspectives from the field
17. Studies on biodiversity of Vietnam and Laos: The UIC-Based ICBG Program
18. The evolution of University of Illinois policy of benefit-sharing in research on natural products
19. The National Cooperative Natural Products Drug Discovery Group (NCNPDDG) and International Cooperative Biodiversity Group (ICBG) programs
20. A sensitive microtiter infectivity assay for macrophage-tropic and primary isolates of HIV-1 based on the transactivation of a stably integrated gene for the green fluorescent protein
21. The vegetation of Cuc Phuong National Park, Vietnam
22. The Latin American ICBG: The first five years
23. Natural products and the development of selective antiprotozoal drugs
24. Antimalarial compounds from Rhaphidophora decursiva
25. Natural anti-HIV agents Part II. Litseaverticillol A, a prototypic litseane sesquiterpene from Litsea verticillata, submitted